Latest in Sales Jump Property

Sort by

594 items

Biogen’s stock hit by soft sales of Alzheimer’s treatment

“We continue to see momentum with ongoing product launches and we are increasingly excited about the potential of our pipeline,” the company’s CEO said.
Business - MarketWatch - October 30
EU to pursue Temu for alleged sale of illegal products

Consumer groups have raised concerns about toxic goods sold on platform
World - Financial Times - October 30
Stellantis hit by sales slide in US and Europe

Fiat, Jeep and Peugeot owner suffers 27% drop in third-quarter sales but signals improvement to US inventory
World - Financial Times - October 31

Biogen’s stock hit by soft sales of Alzheimer’s treatment